Citation Impact
Citing Papers
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Breast cancer
2019 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
2016
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
2014
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Repression of Germline RNAi Pathways in Somatic Cells by Retinoblastoma Pathway Chromatin Complexes
2012 StandoutNobel
The Agrobacterium VirB/VirD4 T4SS: Mechanism and Architecture Defined Through In Vivo Mutagenesis and Chimeric Systems
2018
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
2021
Macrophages in immunoregulation and therapeutics
2023 Standout
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
2018
Management of breast cancer brain metastases: A practical review
2016
Dictionary learning for integrative, multimodal and scalable single-cell analysis
2023 Standout
Cellular mechanisms of tumour suppression by the retinoblastoma gene
2008
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
The current state of preclinical prostate cancer animal models
2008
A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse
2018
Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
2016
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
2019
Cryo-EM structure of a type IV secretion system
2022 StandoutNatureNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Clinical usefulness of liposomal formulations in cancer therapy: lessons from the experiences of doxorubicin
2018
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Effect of circadian clock mutations on DNA damage response in mammalian cells
2012 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
The Effects of Nanoparticle Drug Loading on the Pharmacokinetics of Anticancer Agents
2015
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
TAM Receptor Inhibition–Implications for Cancer and the Immune System
2021
Works of Ryan Bash being referenced
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer
2015
Attachment to Roots and Virulence of a chvB Mutant of Agrobacterium tumefaciens Are Temperature Sensitive
2002
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
2013
Deciphering Cancer Complexities in Genetically Engineered Mice
2005
MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment
2020
MerTK as a therapeutic target in glioblastoma
2017